| [1] |
STARK Z, SCOTT R H. Genomic newborn screening for rare diseases[J]. Nat Rev Genet, 2023, 24(11):755-766.
DOI
|
| [2] |
LI X, WU L, YU L, et al. Policy analysis in the field of rare diseases in China:a combined study of content analysis and bibliometrics analysis[J]. Front Med(Lausanne), 2023, 10:1180550.
|
| [3] |
ROSE N C, BARRIE E S, MALINOWSKI J, et al. Systematic evidence-based review:the application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies[J]. Genet Med, 2022, 24(7):1379-1391.
DOI
URL
|
| [4] |
PRICE C M. Fluorescence in situ hybridization[J]. Blood Rev, 1993, 7(2):127-134.
PMID
|
| [5] |
PARDO E, MORGADO J M T, MALPICA N. Semantic segmentation of mFISH images using convolutional networks[J]. Cytometry A, 2018, 93(6):620-627.
DOI
URL
|
| [6] |
SCHRÖCK E, DU MANOIR S, VELDMAN T, et al. Multicolor spectral karyotyping of human chromosomes[J]. Science, 1996, 273(5274):494-497.
DOI
PMID
|
| [7] |
YAO T Y, WU W J, LAW K S, et al. Prenatal diagnosis of true fetal mosaicism with small supernumerary marker chromosome derived from chromosome 16 by funipuncture and molecular cytogenetics including chromosome microarray[J]. Diagnostics(Basel), 2021, 11(8):1457.
|
| [8] |
CHUNG W K, ROBERTS T P, SHERR E H, et al. 16p11.2 Deletion syndrome[J]. Curr Opin Genet Dev, 2021, 68:49-56.
DOI
PMID
|
| [9] |
DUGOFF L, NORTON M E, KULLER J A. The use of chromosomal microarray for prenatal diagnosis[J]. Am J Obstet Gynecol, 2016, 215(4):B2-B9.
|
| [10] |
CARVALHO C M, ZHANG F, LUPSKI J R. Evolution in health and medicine Sackler colloquium: genomic disorders:a window into human gene and genome evolution[J]. Proc Natl Acad Sci U S A, 2010, 107(Suppl 1):1765-1771.
DOI
URL
|
| [11] |
ESCARAMÍS G, DOCAMPO E, RABIONET R. A decade of structural variants: description,history and methods to detect structural variation[J]. Brief Funct Genomics, 2015, 14(5):305-314.
DOI
URL
|
| [12] |
MA J, AI X, WANG J, et al. Multiplex ligation-dependent probe amplification identifies copy number changes in normal and undetectable karyotype MDS patients[J]. Ann Hematol, 2021, 100(9):2207-2214.
DOI
PMID
|
| [13] |
SMITH A C, NEVELING K, KANAGAL-SHAMANNA R. Optical genome mapping for structural variation analysis in hematologic malignancies[J]. Am J Hematol, 2022, 97(7):975-982.
DOI
URL
|
| [14] |
ZHANG Q, WANG Y, XU Y, et al. Optical genome mapping for detection of chromosomal aberrations in prenatal diagnosis[J]. Acta Obstet Gynecol Scand, 2023, 102(8):1053-1062.
DOI
URL
|
| [15] |
DI TORO A, URTIS M, NARULA N, et al. Impediments to heart transplantation in adults with MELASMT-TL1:m.3243A>G cardiomyopathy[J]. J Am Coll Cardiol, 2022, 80(15):1431-1443.
DOI
URL
|
| [16] |
GUERRERO-MOLINA M P, MORALES-CONEJO M, DELMIRO A, et al. High-dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy,lactic acidosis and stroke-like episodes syndrome[J]. Eur J Neurol, 2023, 30(2):538-547.
DOI
URL
|
| [17] |
EL-HATTAB A W, ADESINA A M, JONES J, et al. MELAS syndrome:clinical manifestations,pathogenesis,and treatment options[J]. Mol Genet Metab, 2015, 116(1-2):4-12.
DOI
URL
|
| [18] |
ORSUCCI D, CALDARAZZO LENCO E, MONTANO V, et al. Mitochondrial stroke-like episodes:the search for new therapies[J]. Pharmacol Res, 2022, 180:106228.
DOI
URL
|
| [19] |
LIANG Q, LIU Y, LIU Y, et al. Comprehensive analysis of fragile X syndrome:full characterization of the FMR1 locus by long-read sequencing[J]. Clin Chem, 2022, 68(12):1529-1540.
DOI
URL
|
| [20] |
EGGERMANN T, MONK D, DE NANCLARES G P, et al. Imprinting disorders[J]. Nat Rev Dis Primers, 2023, 9(1):33.
DOI
PMID
|
| [21] |
WORTMANN S B, OUD M M, ALDERS M, et al. How to proceed after “negative” exome:a review on genetic diagnostics,limitations,challenges,and emerging new multiomics techniques[J]. J Inherit Metab Dis, 2022, 45(4):663-681.
DOI
URL
|
)
